Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

573 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sex differences in immunotherapy outcomes and tumor-infiltrating immune cell profiles in patients with advanced renal cell carcinoma.
Ishihara H, Fukuda H, Mizoguchi Y, Yamashita M, Aoki K, Ishiyama R, Ikeda T, Nemoto Y, Shimmura H, Hashimoto Y, Yoshida K, Hirai T, Iizuka J, Tokita D, Kondo T, Nagashima Y, Takagi T. Ishihara H, et al. Among authors: nemoto y. Cancer Immunol Immunother. 2025 Jan 3;74(2):51. doi: 10.1007/s00262-024-03876-2. Cancer Immunol Immunother. 2025. PMID: 39751827 Free PMC article.
Effects of low-level laser irradiation on canine fibroblasts.
Purba MS, Anggoro D, Itoh H, Itamoto K, Nemoto Y, Nakaichi M, Sunahara H, Tani K. Purba MS, et al. Among authors: nemoto y. J Vet Med Sci. 2024 Nov 13. doi: 10.1292/jvms.24-0318. Online ahead of print. J Vet Med Sci. 2024. PMID: 39537157 Free article.
Changes in outcome of patients with advanced non-clear cell renal cell carcinoma from the tyrosine kinase inhibitor era to the immuno-oncology era.
Ishihara H, Nemoto Y, Mizoguchi S, Nishimura K, Ikeda T, Fukuda H, Yoshida K, Shimmura H, Hashimoto Y, Iizuka J, Kondo T, Takagi T. Ishihara H, et al. Among authors: nemoto y. Int J Clin Oncol. 2024 Nov;29(11):1730-1739. doi: 10.1007/s10147-024-02606-z. Epub 2024 Aug 14. Int J Clin Oncol. 2024. PMID: 39143429
Prognostic Impact of the Administration of Antibiotics and Proton Pump Inhibitors in Immune Checkpoint Inhibitor Combination Therapy for Advanced Renal Cell Carcinoma.
Katsurayama N, Ishihara H, Ishiyama R, Nemoto Y, Ikeda T, Mizoguchi S, Nakayama T, Fukuda H, Yoshida K, Iizuka J, Shinmura H, Hashimoto Y, Kondo T, Takagi T. Katsurayama N, et al. Among authors: nemoto y. Cancer Diagn Progn. 2024 Jul 3;4(4):496-502. doi: 10.21873/cdp.10354. eCollection 2024 Jul-Aug. Cancer Diagn Progn. 2024. PMID: 38962540 Free PMC article.
Survival Impact of Glucocorticoid Administration for Adverse Events During Immune Checkpoint Inhibitor Combination Therapy in Patients with Previously Untreated Advanced Renal Cell Carcinoma.
Yoshino M, Ishihara H, Nemoto Y, Mizoguchi S, Ikeda T, Nakayama T, Fukuda H, Yoshida K, Iizuka J, Shimmura H, Hashimoto Y, Kondo T, Takagi T. Yoshino M, et al. Among authors: nemoto y. Target Oncol. 2024 Jul;19(4):623-633. doi: 10.1007/s11523-024-01069-6. Epub 2024 May 31. Target Oncol. 2024. PMID: 38819770
573 results